ES2189365T3 - Nuevos derivados de eritromicina, su procedimiento de preparacion y su aplicacion como medicamentos. - Google Patents

Nuevos derivados de eritromicina, su procedimiento de preparacion y su aplicacion como medicamentos.

Info

Publication number
ES2189365T3
ES2189365T3 ES99402783T ES99402783T ES2189365T3 ES 2189365 T3 ES2189365 T3 ES 2189365T3 ES 99402783 T ES99402783 T ES 99402783T ES 99402783 T ES99402783 T ES 99402783T ES 2189365 T3 ES2189365 T3 ES 2189365T3
Authority
ES
Spain
Prior art keywords
erythromycin
medicines
application
preparation procedure
new derivatives
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES99402783T
Other languages
English (en)
Inventor
Constantin Agouridas
Alexis Denis
Claude Fromentin
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Aventis Pharma SA
Original Assignee
Aventis Pharma SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharma SA filed Critical Aventis Pharma SA
Application granted granted Critical
Publication of ES2189365T3 publication Critical patent/ES2189365T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/64—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms, e.g. histidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H1/00—Processes for the preparation of sugar derivatives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/08—Hetero rings containing eight or more ring members, e.g. erythromycins

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Communicable Diseases (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)

Abstract

Productos químicos, los compuestos de fórmula (I) **fórmula** así como sus sales de adición con ácidos en la que X representa un átomo de hidrógeno o un átomo de halógeno y Z representa un átomo de hidrógeno o el resto de un ácido.
ES99402783T 1998-11-10 1999-11-09 Nuevos derivados de eritromicina, su procedimiento de preparacion y su aplicacion como medicamentos. Expired - Lifetime ES2189365T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9814145A FR2785612A1 (fr) 1998-11-10 1998-11-10 Nouveaux derives de l'erythromycine, leur procede de preparation et leur application comme medicaments

Publications (1)

Publication Number Publication Date
ES2189365T3 true ES2189365T3 (es) 2003-07-01

Family

ID=9532584

Family Applications (1)

Application Number Title Priority Date Filing Date
ES99402783T Expired - Lifetime ES2189365T3 (es) 1998-11-10 1999-11-09 Nuevos derivados de eritromicina, su procedimiento de preparacion y su aplicacion como medicamentos.

Country Status (28)

Country Link
US (2) US6455505B2 (es)
EP (1) EP1016669B1 (es)
JP (1) JP4698783B2 (es)
KR (1) KR100567695B1 (es)
CN (2) CN100351238C (es)
AR (1) AR025814A1 (es)
AT (1) ATE232879T1 (es)
AU (1) AU766138B2 (es)
BR (1) BR9915236A (es)
CA (1) CA2350651C (es)
CZ (1) CZ20011622A3 (es)
DE (1) DE69905447T2 (es)
DK (1) DK1016669T3 (es)
EA (1) EA200100533A1 (es)
ES (1) ES2189365T3 (es)
FR (1) FR2785612A1 (es)
HR (1) HRP20010335B1 (es)
HU (1) HUP0104035A3 (es)
IL (2) IL142996A0 (es)
NO (1) NO20012272L (es)
NZ (1) NZ511609A (es)
PL (1) PL348098A1 (es)
PT (1) PT1016669E (es)
SI (1) SI20640A (es)
TR (1) TR200101286T2 (es)
TW (1) TWI237027B (es)
WO (1) WO2000027857A2 (es)
ZA (1) ZA200103801B (es)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20020002380A (ko) 1999-01-27 2002-01-09 실버스타인 아써 에이. 케톨라이드 항생물질
EA200100983A1 (ru) 1999-05-24 2002-10-31 Пфайзер Продактс Инк. Производные 13-метилэритромицина
PT1167376E (pt) 2000-06-30 2004-09-30 Pfizer Prod Inc Antibioticos macrolidos
JP2004017020A (ja) * 2002-06-20 2004-01-22 Sony Corp コーティング方法および被コーティング粒子
WO2004080391A2 (en) 2003-03-10 2004-09-23 Optimer Pharmaceuticals, Inc. Novel antibacterial agents
RU2397987C2 (ru) * 2004-07-28 2010-08-27 Рэнбакси Лабораториз Лимитед Кетолидные производные в качестве антибактериальных агентов
WO2006046112A2 (en) * 2004-10-25 2006-05-04 Ranbaxy Laboratories Limited Ketolide derivatives as antibacterial agents
CA2703475A1 (en) 2007-10-25 2009-04-30 Cempra Pharmaceuticals, Inc. Process for the preparation of macrolide antibacterial agents
EP2358379B1 (en) * 2008-10-24 2015-12-16 Cempra Pharmaceuticals, Inc. Biodefenses using triazole-containing macrolides
US9937194B1 (en) 2009-06-12 2018-04-10 Cempra Pharmaceuticals, Inc. Compounds and methods for treating inflammatory diseases
US9480679B2 (en) 2009-09-10 2016-11-01 Cempra Pharmaceuticals, Inc. Methods for treating malaria, tuberculosis and MAC diseases
PL2550286T3 (pl) 2010-03-22 2016-07-29 Cempra Pharmaceuticals Inc Krystaliczne postaci makrolidu i ich zastosowanie
CN102917708B (zh) 2010-05-20 2015-11-25 森普拉制药公司 制备大环内酯和酮内酯及其中间体的方法
US9815863B2 (en) 2010-09-10 2017-11-14 Cempra Pharmaceuticals, Inc. Hydrogen bond forming fluoro ketolides for treating diseases
CN104470527B (zh) 2012-03-27 2019-05-28 森普拉制药公司 用于施用大环内酯抗生素的肠胃外制剂
WO2014152326A1 (en) 2013-03-14 2014-09-25 Cempra Pharmaceuticals, Inc. Methods for treating respiratory diseases and formulations therefor
US9751908B2 (en) 2013-03-15 2017-09-05 Cempra Pharmaceuticals, Inc. Convergent processes for preparing macrolide antibacterial agents
CA3130061C (en) 2013-04-04 2024-05-28 President And Fellows Of Harvard College Macrolides and methods of their preparation and use
EP3211997A4 (en) 2014-10-08 2018-10-24 President and Fellows of Harvard College 14-membered ketolides and methods of their preparation and use
CA2980315A1 (en) 2015-03-25 2016-09-29 President And Fellows Of Harvard College Macrolides with modified desosamine sugars and uses thereof
EP3190122A1 (en) * 2016-01-08 2017-07-12 LEK Pharmaceuticals d.d. A novel synthetic pathway towards solithromycin and purification thereof
CN106432383A (zh) * 2016-09-14 2017-02-22 重庆两江药物研发中心有限公司 索利霉素及其中间体的制备方法

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5671074A (en) * 1979-11-12 1981-06-13 Takeda Chem Ind Ltd 1,2-disubstituted-4-halogenoimidazole-5-acetic acid derivative
FR2669337B1 (fr) * 1990-11-21 1995-03-24 Roussel Uclaf Nouveaux derives descladinosyles de l'erythromycine, leur procede de preparation et leur application comme medicaments.
IL114589A (en) * 1990-11-21 1999-12-22 Roussel Uclaf Intermediates for the preparation of the history of erythromycin
US5527780A (en) * 1992-11-05 1996-06-18 Roussel Uclaf Erythromycin derivatives
FR2697524B1 (fr) * 1992-11-05 1994-12-23 Roussel Uclaf Nouveaux dérivés de l'érythromycine, leur procédé de préparation et leur application comme médicaments.
FR2719587B1 (fr) * 1994-05-03 1996-07-12 Roussel Uclaf Nouveaux dérivés de l'érythromycine, leur procédé de préparation et leur application comme médicaments.
FR2727969B1 (fr) * 1994-12-09 1997-01-17 Roussel Uclaf Nouveaux derives de l'erythromycine, leur procede de preparation et leur application comme medicaments
FR2742757B1 (fr) * 1995-12-22 1998-01-30 Roussel Uclaf Nouveaux derives de l'erythromycine, leur procede de preparation et leur application comme medicaments
ATE299508T1 (de) * 1996-09-04 2005-07-15 Abbott Lab 6-o-substituierte ketoliden mit antibakteriellen wirkung
US6165986A (en) * 1997-03-10 2000-12-26 Taisho Pharmaceutical Co., Ltd. Erythromycin a derivatives

Also Published As

Publication number Publication date
TR200101286T2 (tr) 2001-09-21
HRP20010335A2 (en) 2002-06-30
NZ511609A (en) 2003-07-25
AR025814A1 (es) 2002-12-18
FR2785612A1 (fr) 2000-05-12
CN1333782A (zh) 2002-01-30
PL348098A1 (en) 2002-05-06
AU1052600A (en) 2000-05-29
CN1240708C (zh) 2006-02-08
CA2350651C (fr) 2010-07-20
ATE232879T1 (de) 2003-03-15
US20020013281A1 (en) 2002-01-31
AU766138B2 (en) 2003-10-09
CA2350651A1 (fr) 2000-05-18
HUP0104035A3 (en) 2003-12-29
EA200100533A1 (ru) 2001-10-22
JP4698783B2 (ja) 2011-06-08
IL142996A (en) 2006-12-10
HRP20010335B1 (en) 2003-08-31
DE69905447D1 (de) 2003-03-27
KR20010080970A (ko) 2001-08-25
NO20012272L (no) 2001-07-10
PT1016669E (pt) 2003-07-31
JP2000143689A (ja) 2000-05-26
CN100351238C (zh) 2007-11-28
WO2000027857A3 (fr) 2000-08-17
BR9915236A (pt) 2002-01-08
NO20012272D0 (no) 2001-05-09
DE69905447T2 (de) 2003-07-24
KR100567695B1 (ko) 2006-04-05
WO2000027857A2 (fr) 2000-05-18
CN1814592A (zh) 2006-08-09
US6407257B1 (en) 2002-06-18
CZ20011622A3 (cs) 2001-09-12
SI20640A (sl) 2002-02-28
IL142996A0 (en) 2002-04-21
EP1016669A1 (fr) 2000-07-05
HUP0104035A2 (hu) 2002-02-28
TWI237027B (en) 2005-08-01
US20020028781A1 (en) 2002-03-07
ZA200103801B (en) 2002-05-10
DK1016669T3 (da) 2003-05-26
US6455505B2 (en) 2002-09-24
EP1016669B1 (fr) 2003-02-19

Similar Documents

Publication Publication Date Title
ES2189365T3 (es) Nuevos derivados de eritromicina, su procedimiento de preparacion y su aplicacion como medicamentos.
ECSP034460A (es) Nuevos compuestos heterociclicos, su preparacion y su utilizacion como medicamentos, en especial como antibacterianos
AR021844A1 (es) Derivados de propanolamina aril-sustituidos, procedimientos para su preparacion, medicamentos que contienen estos compuestos y su utilizacion
RS49673B (sr) Inhibitori sintaze azot-monoksida
ES2066620T3 (es) Nuevos derivados de perhidroisoindol y su preparacion.
BR9913745A (pt) Cetonas de piridina úteis como herbicidas
BR0111981A (pt) herbicidas de piridina substituìda
DK0931788T3 (da) Metalloproteasehæmmere
TR200100623T2 (tr) 5-Tia-w-ikameli fenil-prostaglandin türevleri, bunları üretme yöntemleri ve müessir madde olarak bunları ihtiva eden ilaçlar
ES2160046B1 (es) Derivados pentapeptidicos.
MX9204111A (es) Triazoles substituidos y procedimiento para su obtencion.
NO20023981L (no) Antivirale azaindol-derivater
BR0207278A (pt) Derivados de ftalazinona-piperidina como inibidores de pde4
CY1110258T1 (el) Υποκατεστημενα παραγωγα c-κυκλοεξυλομεθυλαμινης
PT1082109E (pt) Formulacao oral que compreende biguanidina e um acido organico
MX164399B (es) Composiciones generadoras de gas que contienen sales de acido 5-nitrobarbiturico,sales de acido nitroorotico o 5-nitrouracilo
ES2100314T3 (es) Derivados de la pirimidina, su procedimiento de preparacion, productos intermedios obtenidos, su aplicacion como medicamentos y composiciones farmaceuticas que las contienen.
UY26675A1 (es) Sales de imidazo-3-aminas e imidazo-5-aminas bicíclicas n-aciladas y sus productos de adicción con ácidos, procedimientos para su preparación y medicamentos que contienen estos compuestos
AR020563A1 (es) Compuestos (poli)tia-alquinoicos y sus derivados, composiciones que los incluyen y su utilizacion
ES2032752T3 (es) Procedimiento de preparacion de derivados de la 1-bencenosulfonil-2-oxo-5-alcoxi-pirrolidina.
BRPI0415034A (pt) derivados de aminopiridina como inibidores de não-sintase induzìveis
CY1106712T1 (el) Υποκατεστημενα παραγωγα 5-αμινο-1-πεντεν-3-ολης
ES2189736T3 (es) Derivados de la benzamida y medicamentos que los contienen.
DK162682A (da) Oxindolderivater,deres fremstilling og anvendelse
ES2172294T3 (es) Nuevos derivados del 1-indanol, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen.